Search results for " biotechnology"
Article
Maximum Output Starts with Optimized Upstream Processing
Some other companies that have recently completed or announced new capacity include Matica Biotechnology, Porton Biologics, Fujifilm Diosynth Biotechnologies, Oxford Biomedica, Emergent BioSolutions, …
Article
Updating Viral Clearance for New Biologic Modalities
ICH, Q5A Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin (1999).
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The company will also hire nearly 1000 personnel in key areas as part of its strategy to support long-term growth in the biotechnology industry.
The investment will include new manufacturing lines …
Article
Single-Use for Downstream Chromatography: Benefit or Hindrance?
Xenopoulos, Journal of Biotechnology 213, 42–53 (2015).
Article
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
Acknowledgements
This work was funded by the Center of Excellence for Biopharmaceutical Technology grant under Department of Biotechnology, Government of India.
References
1. R. Karlsson, …
Article
Biopharma Seeks Balance
According to a Biotechnology Innovation Organization report (1) overall investment trends for R&D-stage companies were up in 2017 compared with 2016, despite a drop in the number of acquisitions. Gile…
Article
Understanding Validation and Technical Transfer, Part 3
Understanding Validation and Technical Transfer, Part 3
Validation ensures safe and effective biologic products that benefit the patients whose health and wellbeing depend on the therapies. Part 1 |…
Article
Preclinical Evaluation of Product Related Impurities and Variants
These drugs have become the centerpiece of biotechnology industry and an integral part of modern medicine, evidenced by the annual global expenditure of $1.2 trillion for 2016 (2). These products also…
Article
Biosimilars to Drive Modern Manufacturing Approaches
Momenta Pharmaceuticals CEO Craig Wheeler agreed that advances in biotechnology manufacturing and efficient plant utilization will be key over the long term for biosimilars to provide an expected 30-4…
Article
Analysis of Glycosylation in Biosimilars
A step-wise process is used to characterize glycans and understand the functioning of a molecule for biosimilar development.
The structures of protein drugs such as monoclonal antibodies are mad…